MedTrace Logo

Safety and Efficacy of Cryoballoon Ablation of Atrial Fibrillation as First-line Therapy

NCT01920295 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2013-08-09

No results posted yet for this study

Summary

Cryoballoon ablation of paroxysmal atrial fibrillation can be used as first-line therapy compared to second choice after failed medical therapy

Conditions

  • Paroxysmal Atrial Fibrillation

Interventions

DEVICE

Cryoballoon ablation

Sponsors & Collaborators

  • Yuksek Ihtisas Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2013-03-31
Completion
2013-04-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01920295 on ClinicalTrials.gov